Arrieta A et al. |
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506028
|
Bingen E et al. |
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821495
|
Matlow A et al. |
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593171
|
Pettus K et al. |
In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25624328
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Mulet X et al. |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19188376
|
Jacobsson S et al. |
Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28893785
|
Seyama S et al. |
Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28848006
|
Caceres SM et al. |
Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25182651
|
Jacobs MR et al. |
Study design questions in treatment of children with acute otitis media. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15241848
|
Kemp MW et al. |
Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155606
|
Blandizzi C et al. |
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959610
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Zheng S et al. |
Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155592
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Descours G et al. |
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28069647
|
Engel JN |
Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1280057
|
Saini H et al. |
Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28031194
|
Girgis NI et al. |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348767
|
Starner TD et al. |
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. |
2008 |
Antimicrob. Agents Chemother. |
pmid:17954687
|
Mukherjee P et al. |
Emergence of high-level azithromycin resistance in Campylobacter jejuni isolates from pediatric diarrhea patients in Kolkata, India. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24777098
|
Achard A et al. |
Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18519724
|
Zasowski E et al. |
Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752270
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Wong MH et al. |
Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752251
|
Yoshioka D et al. |
Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480866
|
Jeong BH et al. |
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480854
|
Clark CL et al. |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876003
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Andersen SL et al. |
Efficacy of azithromycin as a causal prophylactic agent against murine malaria. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986022
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Mandell GL and Coleman EJ |
Activities of antimicrobial agents against intracellular pneumococci. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10952618
|
Frank MO et al. |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336337
|
O'Reilly T et al. |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336342
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Bermudez LE and Young LS |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2847644
|
Salman S et al. |
Pharmacokinetics of Transfer of Azithromycin into the Breast Milk of African Mothers. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711756
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Bergman M et al. |
Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16940064
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Araujo FG et al. |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840017
|
Yamaguchi H et al. |
Chlamydia pneumoniae resists antibiotics in lymphocytes. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760877
|
Kutlin A et al. |
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796350
|
Jacks SS et al. |
In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709351
|
Roord JJ et al. |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124837
|
Gödeke J et al. |
Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318806
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|